Cavanagh Bethany J Insider Trades

Insider Trading History

Track insider trading activity for Cavanagh Bethany J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.68M 51,171 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$79.7k 3,242 shares
$24.58
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.8M 54,813 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$477k 20,000 shares
$23.83
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.31M 40,000 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1M 40,000 shares
$27.62
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.14M 34,813 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$217k 6,198 shares
$35.00
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.35M 41,011 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$91.4k 3,034 shares
$30.12
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.45M 44,045 shares
Last Trade
Oct 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.5k 467 shares
$24.53
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.46M 44,512 shares
Last Trade
Apr 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$55.3k 3,015 shares
$18.35
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.56M 47,527 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 10,000 shares
$19.53
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.23M 37,527 shares
Last Trade
Feb 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$220k 6,287 shares
$35.00
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $657k 20,000 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$518k 20,000 shares
$25.92
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.44M 43,814 shares
Last Trade
Jan 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.6k 1,117 shares
$24.68
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.48M 44,931 shares
Last Trade
Oct 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.79k 289 shares
$23.48
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.49M 45,220 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.3k 2,500 shares
$24.50
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $164k 5,000 shares
Last Trade
Aug 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 5,000 shares
$26.68
$32.84
Beam Therapeutics
Beam Therapeutics BEAM
Svp, Finance And Treasurer
Holding Value $1.4M 42,720 shares
Last Trade
Aug 09, 2024 Sale
$1.54M 63,042 shares
$24.46
$32.84

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up